3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Gastroparesis
1
Esophageal Motility Disorders
1
Esophageal Diseases
1
Esophageal Achalasia
1
Interventions
pembrolizumab
606
Cyclophosphamide
546
Magnetic Resonance Spectroscopy
527
Radiotherapy
514
Specimen Handling
506
Nivolumab
412
Cisplatin
381
Carboplatin
369
Biopsy
306
Blood Specimen Collection
304
Radiosurgery
290
Paclitaxel
281
Gemcitabine
271
Surveys and Questionnaires
270
Standard of Care
267
Drug Therapy
264
fludarabine
263
Dexamethasone
263
Bevacizumab
253
venetoclax
251
Oxaliplatin
209
Capecitabine
201
Rituximab
199
Radiation
192
Fluorouracil
189
Ipilimumab
188
durvalumab
185
Doxorubicin
179
Etoposide
177
atezolizumab
175
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pyloromyotomy
×
1 year
×
Clear all
NCT06721520
2026-02-25
EMPTY
The Cleveland Clinic
Phase 2/3
Recruiting
170 enrolled